跳至主要内容
临床试验/NCT03696563
NCT03696563Unknown不适用

Automated Administration of Oxygen Using the FreeO2 Device in Ambulances for COPD and Trauma Patients: A Feasibility Study

François Lellouche0 个研究点目标入组 100 人开始时间: 2021年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
主要终点
Feasibility of the study design - Paramedics survey

研究概览

简要总结

Evaluation of automated oxygen titration in comparison with manual adjustment oxygen in the out-of-hospital setting by paramedics.

详细描述

It is a single center study in Ottawa, Ontario Canada.

This will be a single centered prehospital multi-period cluster crossover feasibility trial, enrolling patients in Ottawa, Ontario, who are treated by paramedics from the Ottawa Paramedic Service, who have been trained in the use of the automated oxygen delivery device. We will be using the FreeO2 device. Patients requiring oxygen therapy during prehospital transportation will be enrolled. No randomization will occur within this single centered feasibility study

Patients requiring oxygen therapy during the prehospital transportation will be enrolled and will be included as soon as they are placed into the ambulance, until handover and transfer of care at receiving hospital.

In both groups, SpO2 will be collected continuously every second with FreeO2 monitoring, in addition to the collection of vital signs carried out by the staff according to the standards.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •COPD patient:
  • •Known or suspected acute exacerbation of COPD. Acute exacerbation is defined by worsening of the respiratory condition for less than 2 weeks. Suspected COPD is defined by patients of at least 30 years old with respiratory symptoms with a past or current smoking history of at least 10 pack years, or
  • •Able to measure SpO2 via pulse oximetry
  • •Trauma patient:
  • •I) Trauma: patients who sustain any trauma (minor or major), II) Able to measure SpO2 via pulse oximetry

排除标准

  • •Inclusion in another study not allowing the co-enrollment
  • •Pregnancy
  • •Age <18 years
  • •Prehospital Invasive or non-invasive mechanical ventilation
  • •Meeting high concentration oxygen administration injury or condition (as per BLS-PCS Oxygen Therapy Standard (Version 3.0), s(2)a-f).

研究组 & 干预措施

Control group

Active Comparator

In this group, the - usual care based upon BLS-PCS with manual titration of oxygen. In this group the SpO2 was recorded any time with FreeO2 device - recording mode.

干预措施: Standard administration of oxygen flow (Other)

FreeO2 group

Experimental

The adjustment of the oxygen flow will be made by the FreeO2 system, an automated titration to reach the SpO2 target set by paramedic.

干预措施: Automated oxygen administration - FreeO2 (Device)

结局指标

主要结局

Feasibility of the study design - Paramedics survey

时间窗: through study completion, an average of 1 year

A survey will be complete by Paramedics at the end of day of transportation (day 1); the target response rate is 75% of case.

Feasibility of the study design - Evaluation of data collection tool

时间窗: through study completion, an average of 1 year

target: 100% of data captured in \>90% cases

Feasibility of the study design - REB approval

时间窗: Date of REB submission to date of REB approval, target: until 3 months (90 days) from REB submission

Time to REB approval for single site time to REB approval for single site define by below 3 months (90 days) from REB submission, time to readiness to initiate the clinical trial after REB approval - below 3 months (90 days) from REB approval, evaluation of data collection tool - 100% of data captured in \>90% case at hospital discharge (until day 28), Survey responses from Paramedics - At the end of the transportation day

Feasibility of the study design - initiate the clinical trial

时间窗: Target until 3 months (90 days) from REB approval

Time to readiness to initiate the clinical trial

Feasibility of the study design - study protocol compliance

时间窗: through study completion,an average of 1 year

Target of 80% of compliance for protocol intervention/control group

次要结局

  • The oxygentherapy complication- PaCO2(Day 1- On The first ABG or capillary blood gases after hospital admission)
  • The oxygentherapy complication - respiratory acidosis(Day 1- On The first ABG or capillary blood gases after hospital admission)
  • The rate of patients without oxygen at the end of the transportation(Day 1 - At the end of the transportation (at the exit from the ambulance))
  • Oxygenation - Total time with hyperoxia(Day 1 - During prehospital transportation (from entry in the ambulance until exit of the ambulance))
  • Oxygenation - Total Time in the target zone SpO2(Day 1 - During prehospital transportation (from entry in the ambulance until exit of the ambulance))
  • Outcome data - NIV(through study completion, an average of 1 year)
  • Outcome data(Length of hospital stay measured in calendar days, hospital admission through study completion, up to 8 weeks)
  • Oxygenation - Total time with hypoxemia(Day 1 - During prehospital transportation (from entry in the ambulance until exit of the ambulance))
  • Outcome data - Death(During hospital stay - hospital admission through study completion or until death if occured, up to 8 weeks)
  • Outcome data - ICU admission(through study completion, an average of 1 year)
  • The oxygen consumption during the pre-hospital transport(Day 1 - During prehospital transportation (from entry in the ambulance until exit of the ambulance),)

研究者

发起方
François Lellouche
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

François Lellouche

Sponsor

Laval University

相似试验